Search Back New search Go to resultsDiseaseMain groupSolid TumorsSupportive Therapy, ToxicityProtocol groupComplicationsGynecological OncologyDiseaseBone MetastasesHypercalcemia of MalignancyOsteolysisSubgroupICD10C79.5E83.59M89.5-MeSHHypercalcemiaOsteolysisSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionClodronic acidDenosumabIbandron AcidZoledronic AcidSupportive substanceBalanced Crystalloid SolutionClodronic acidDenosumabIbandron AcidZoledronic AcidSupportive substanceBalanced Crystalloid SolutionClodronic acidDenosumabIbandron AcidZoledronic AcidSupportive substanceBalanced Crystalloid SolutionClodronic acidDenosumabIbandron AcidZoledronic AcidNo. Substances12Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentionsupportiveRisksBone PainCardiotoxicityCataractDiarrheaDyspneaEmetogenicityHeadacheHypocalcemiaHypophosphatemiaOsteonecrosis of the JawRenal Failure only studiesPublicationAuthorBody JLipton APaterson ARosen LDiseaseBrustkrebs bedingte KnochenmetastasenMamma-Ca mit KnochenmetastasenMamma-Ca mit Knochenmetastasen, ECOG 0-2Mamma-Ca mit Knochenmetastasen, ECOG 0-3mind. 1 Knochenmetastase beim Mamma-Ca mit ECOG 0-2 oder 1 osteolytsche Läsion beim MM Stadium IIIOriginDepartment of Medicine, Tom Baker Cancer Centre, University of Calgary and Alberta Cancer Board, Edmonton, CanadaDevelopmental Therapeutics, Cancer Institute Medical Group, Santa Monica, CaliforniaPenn State Milton S. Hershey Medical Center Oncology, Hershey, PAUniversité Libre de Bruxelles, Institut Jules Bordet, Brussels, BelgiumUniversité Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium, MF 4265 Study GroupProtocols in Revision 5 protocols foundProtocols under revision.Clodronic Acid 1040/520, Bone Metastases (PID945 V1.0)Denosumab 120, Bone Metastases (PID541 V1.1)IbandronAcid 50, Bone Metastases (PID948 V1.0)IbandronAcid 6, Bone Metastases (PID937 V1.0)Zoledronate 4, Bone Metastases (PID936 V1.0)
